Shares of developmental-stage biopharma Checkpoint Therapeutics (NASDAQ: CKPT) rose by as much as 16% in pre-market action Tuesday morning. The biotech stock was heating up in response to a positive ...

What:Shares of Checkpoint Systems climbed 34.8% in March,according to data provided byS&PGlobal Market Intelligence, primarily after the company announced it has agreed to be acquired by an affiliate ...

Shares of Checkpoint Therapeutics (NASDAQ:CKPT) plunged 50% in morning trading Monday after the company said the FDA had declined to approve its drug cosibelimab for the treatment of advanced ...

Given the vastness of the world”s retail market, a person might expect that two companies with what one analyst refers to as a “lock” on technology necessary to retail stores could find a way to ...

Checkpoint Therapeutics (NASDAQ:CKPT) shares fell over 14% premarket on Tuesday after the oncology company announced a securities offering to raise ~$7.5M in gross proceeds. The offering comprises ...

Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What:Shares of ...

WALTHAM, Mass., Dec. 05, 2022 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (Nasdaq: CKPT), a clinical-stage immunotherapy and targeted oncology company, today announced that it ...

Checkpoint Therapeutics, Inc. (CKPT) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful ...